Who has invested in Intellective Bio?

Legend Capital, Gaorong Capital are named among the investors backing Intellective Bio.

Intellective Bio Funding: $74M Raised, IPO (2026)

Intellective Bio funding overview

Intellective Bio is based in Suzhou, China. Intellective Bio has raised $74M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in June 2026. The round record for Intellective Bio runs through 2026; nothing later has been disclosed. Investors on record include Legend Capital, Gaorong Capital. 2 distinct backers are named across the disclosed rounds.

Intellective Bio at a glance

Total raised: $74M
Latest round: IPO
Latest round date: June 2026
Headquarters: Suzhou, China
Notable investors: Legend Capital, Gaorong Capital

Frequently asked about Intellective Bio funding

How much has Intellective Bio raised?: Intellective Bio has raised $74M in total disclosed funding across the rounds on record.
Who has invested in Intellective Bio?: Legend Capital, Gaorong Capital are named among the investors backing Intellective Bio.
What was the latest Intellective Bio funding round?: The most recent disclosed round is an IPO, announced in June 2026.
Where is Intellective Bio based?: Intellective Bio is based in Suzhou, China.
When did Intellective Bio last raise?: The last disclosed Intellective Bio round closed in June 2026 at IPO.

Intellective Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.

Intellective Bio Funding: $74M Raised, IPO (2026)

Intellective Bio funding overview

Intellective Bio at a glance

Frequently asked about Intellective Bio funding

Companies related to Intellective Bio (36)

Browse related funding lists (5)